Product Name: Buparvaquone Injection 50mg/ml
Scheduling status:
Patent name and drug name:
Ingredients: 5g of Buparvaquone per 100 milliliters
[Function and Use] Refers to Lawrence i, T. anulata, T. mutans, and Eastern Lawrence i, T. anulata, T. mutans caused by East Coast fever, corridor diseases, intracellular protozoan parasites, and tropical tapeworms in cattle. It is active in both the mitotic and pear pulp stages of Streptococcus pneumoniae and can be used during disease incubation or when clinical signs are obvious.
[Usage and Dosage] Inject 1 milliliter per 20 kilograms of body weight.
In severe cases, treatment could be repeated within 48-72 hours. The injection should not exceed 10 milliliters in single site. Continuous injections should be administered in different sites. Intramuscular inject in neck muscle.
Contraindications
Due to its inhibitory effect on the immune system, vaccination should be postponed until animals have recovered from Illyriasis.
[Withdrawal period]
Abandoned milk period: 2 days
Livestock and poultry: 42 days
[Storage] Store below 30℃. Avoid sunlight.
